School Of Medicine At Mount Sinai Icahn is > 10% Shareholder of Sema4 Holdings Corp.. Currently has a direct ownership of 123 Million shares of SMFR, which is worth approximately $41.9 Million. The most recent transaction as insider was on Jan 31, 2023, when has been sold 28,571,428 shares (Class A Common Stock) at a price of $0.35 per share, resulting in proceeds of $9,999,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123M
0% 3M change
0% 12M change
Total Value Held $41.9 Million

SCHOOL OF MEDICINE AT MOUNT SINAI ICAHN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 31 2023
BUY
Open market or private purchase
$9,999,999 $0.35 p/Share
28,571,428 Added 18.83%
123,176,901 Class A Common Stock
Apr 29 2022
BUY
Open market or private purchase
$25,000,000 $4.0 p/Share
6,250,000 Added 6.2%
94,605,473 Class A Common Stock

Also insider at

RNLX
Renalytix plc Healthcare
SOM

School Of Medicine At Mount Sinai Icahn

> 10% Shareholder
New York, NY

Track Institutional and Insider Activities on SMFR

Follow Sema4 Holdings Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SMFR shares.

Notify only if

Insider Trading

Get notified when an Sema4 Holdings Corp. insider buys or sells SMFR shares.

Notify only if

News

Receive news related to Sema4 Holdings Corp.

Track Activities on SMFR